| Company/Division name | uBriGene |
| Parent company | uBriGene |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 500 |
| Year reshoring announced: | 2023 |
| Country(ies) from which reshored: | Canada |
| City reshored to: | Worcester |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | multiple gene-modified cell types, cGMP storage |
| What domestic positive factors made reshoring more attractive? | Manufacturing/engineering joint innovation (R&D), Proximity to customers/market, Skilled workforce availability/training |
